Related Experiment Videos

[Budd-Chiari syndrome in children. Apropos of 7 cases]

T Boudhina1, N Ghram, S Ben Becher

  • 1Service de Pédiatrie, Hôpital d'Enfants, Tunis, Tunisie.

Archives Francaises De Pediatrie
|April 1, 1991
PubMed

Insights

This study reports seven pediatric Budd-Chiari syndrome cases, highlighting varied onset and constant hepatomegaly. Surgical shunts improved outcomes in two children, demonstrating potential treatment benefits for this rare liver condition.

Area of Science:

  • Pediatric Hepatology
  • Vascular Liver Diseases
  • Gastroenterology

Background:

  • Budd-Chiari syndrome is a rare condition involving hepatic vein obstruction.
  • Pediatric presentation often differs from adults, necessitating specific diagnostic and management approaches.
  • Understanding the varied clinical spectrum and potential etiologies in children is crucial for timely intervention.

Purpose of the Study:

  • To describe the clinical characteristics, diagnostic methods, and outcomes of Budd-Chiari syndrome in a pediatric cohort.
  • To investigate potential associated conditions and etiologies in children with Budd-Chiari syndrome.
  • To evaluate the efficacy of portasystemic shunts in managing pediatric Budd-Chiari syndrome.

Main Methods:

  • Retrospective case series analysis of seven pediatric patients diagnosed with Budd-Chiari syndrome.
  • Diagnostic modalities included ultrasonography, cavography, hepatic veins angiography, and liver biopsy.
  • Etiologic investigations explored potential underlying causes, including infections and autoimmune conditions.

Main Results:

  • Hepatomegaly was a consistent finding across all seven cases.
  • Onset varied from fulminant liver failure to insidious presentation with isolated hepatomegaly.
  • Associated conditions included total villous atrophy, psoriasis, hepatitis B, hepatitis A, and giardiasis.
  • Portasystemic shunts were performed in three patients, with two achieving good long-term health outcomes.

Conclusions:

  • Budd-Chiari syndrome in children presents with diverse clinical features and variable liver function abnormalities.
  • While definitive etiologies remain elusive in many cases, associated conditions may offer diagnostic clues.
  • Portasystemic shunting appears to be a viable therapeutic option, offering significant long-term benefits for select pediatric patients.

Related Concept Videos